FDA Inspection 1017014 — Somerset Therapeutics Private Limited
The FDA completed an inspection of Somerset Therapeutics Private Limited on Apr 24, 2017 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)